Delayed graft function after renal transplantation
Conditions
Interventions
experimental group:Roxadustat Capsules and routine treatment
control group:routine treatment
Sponsors
The Third Affiliated Hospital of Sun Yat-Sen University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Donors and recipients aged 18-60 years; 2. Patients with indications for renal transplantation; 3. Patients with first kidney transplantation; 4. Renal transplantation with cadaveric donor; 5. Patients willing to sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Renal transplantation with living donor among relatives; 2. Patients with absolute contraindications to renal transplantation; 3. The patients who use the drugs in combination within the non specified scope, especially the drugs that have a great influence on the test results and affect the validity and safety judgment; 4. Patients participating in other clinical trials; 5. Patients with previous history of other organ transplantation; 6. Other situations that the researchers think are not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of delayed graft function, DGF;CD4/CD8; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of acute rejection, AR;panel reactive antibodies, PRA;hemoglobin;Urine volume;BUN;Color Doppler Ultrasound in Patients with Transplanted Kidney; | — |
Countries
China
Contacts
Public ContactQiquan Sun
The Third Affiliated Hospital of Sun Yat-Sen University
Outcome results
None listed